2024 Q2 Form 10-Q Financial Statement
#000184450524000013 Filed on May 13, 2024
Income Statement
| Concept | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|
| Revenue | $1.714M | $1.362M | $0.00 |
| YoY Change | |||
| Cost Of Revenue | $839.5K | $602.1K | |
| YoY Change | 26797.92% | 1192.66% | |
| Gross Profit | $874.6K | $760.1K | |
| YoY Change | 1410466.13% | -2048.27% | |
| Gross Profit Margin | 51.02% | 55.8% | |
| Selling, General & Admin | $2.170M | $5.696M | $743.9K |
| YoY Change | 32.52% | 222.3% | -53.24% |
| % of Gross Profit | 248.07% | 749.42% | |
| Research & Development | $925.1K | $642.5K | |
| YoY Change | 164.57% | 52.3% | |
| % of Gross Profit | 105.78% | 84.54% | |
| Depreciation & Amortization | $42.23K | $98.87K | |
| YoY Change | -39.29% | -15.37% | |
| % of Gross Profit | 4.83% | 13.01% | |
| Operating Expenses | $3.095M | $6.339M | $743.9K |
| YoY Change | 89.03% | 258.66% | -53.24% |
| Operating Profit | -$2.220M | -$5.579M | |
| YoY Change | 35.61% | 215.65% | |
| Interest Expense | -$1.095M | -$599.0K | $233.4K |
| YoY Change | -2046.17% | -1495.75% | -28.55% |
| % of Operating Profit | |||
| Other Income/Expense, Net | $336.6K | -$1.104M | $23.50K |
| YoY Change | 2401.49% | 110305.0% | -531.99% |
| Pretax Income | -$1.249M | -$4.299M | -$487.0K |
| YoY Change | -4.79% | 214.23% | -61.64% |
| Income Tax | $84.80K | ||
| % Of Pretax Income | |||
| Net Earnings | -$1.249M | -$4.299M | -$571.8K |
| YoY Change | -11.82% | 191.85% | -58.34% |
| Net Earnings / Revenue | -72.86% | -315.57% | |
| Basic Earnings Per Share | -$0.30 | -$0.33 | |
| Diluted Earnings Per Share | -$0.30 | -$0.33 | -$0.05 |
| COMMON SHARES | |||
| Basic Shares Outstanding | 21.44M shares | 21.44M | 8.660M |
| Diluted Shares Outstanding | 21.44M shares | 13.23M shares |
Balance Sheet
| Concept | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $4.581M | $5.620M | $2.000K |
| YoY Change | 61145.19% | 1478.1% | -97.44% |
| Cash & Equivalents | $4.601M | $5.640M | $2.438K |
| Short-Term Investments | |||
| Other Short-Term Assets | $889.5K | $1.215M | $94.00K |
| YoY Change | 1802.61% | 989.85% | -45.51% |
| Inventory | $3.355M | $4.116M | $4.418M |
| Prepaid Expenses | |||
| Receivables | $669.1K | $482.4K | $1.290K |
| Other Receivables | $0.00 | $0.00 | |
| Total Short-Term Assets | $9.494M | $11.43M | $96.45K |
| YoY Change | 17408.99% | 2344.99% | -61.53% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $141.7K | $154.1K | $490.9K |
| YoY Change | |||
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | $23.30M | ||
| YoY Change | -44.11% | ||
| Other Assets | $39.15K | $39.15K | $39.15K |
| YoY Change | |||
| Total Long-Term Assets | $1.286M | $1.424M | $23.30M |
| YoY Change | -96.04% | -95.53% | -44.11% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $9.494M | $11.43M | $96.45K |
| Total Long-Term Assets | $1.286M | $1.424M | $23.30M |
| Total Assets | $10.78M | $12.86M | $23.40M |
| YoY Change | -66.88% | -60.19% | -44.22% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $549.6K | $711.8K | $767.6K |
| YoY Change | 21.08% | 98.98% | 293.52% |
| Accrued Expenses | $4.192M | $2.813M | $893.8K |
| YoY Change | 495.81% | 1610.56% | 764.91% |
| Deferred Revenue | $31.75K | $343.7K | $347.6K |
| YoY Change | |||
| Short-Term Debt | $5.409M | $0.00 | $4.682M |
| YoY Change | 56.89% | -100.0% | 184.98% |
| Long-Term Debt Due | $4.294M | $130.7K | |
| YoY Change | |||
| Total Short-Term Liabilities | $15.27M | $4.371M | $12.68M |
| YoY Change | 90.3% | -31.75% | 202.95% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $36.70K | $8.739M | $0.00 |
| YoY Change | |||
| Other Long-Term Liabilities | $0.00 | $465.1K | $377.8K |
| YoY Change | -100.0% | -83.29% | -95.91% |
| Total Long-Term Liabilities | $0.00 | $465.1K | $377.8K |
| YoY Change | -100.0% | -83.29% | -95.91% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $15.27M | $4.371M | $12.68M |
| Total Long-Term Liabilities | $0.00 | $465.1K | $377.8K |
| Total Liabilities | $16.94M | $17.77M | $12.69M |
| YoY Change | 56.87% | 93.41% | -5.42% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$28.50M | -$22.07M | -$17.10M |
| YoY Change | 78.49% | 51.64% | 30.77% |
| Common Stock | $2.144K | $2.144K | $4.590M |
| YoY Change | -99.96% | -99.96% | 700638.02% |
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | -$6.159M | -$4.914M | -$12.51M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $10.78M | $12.86M | $23.40M |
| YoY Change | -66.88% | -60.19% | -44.22% |
Cashflow Statement
| Concept | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$1.249M | -$4.299M | -$571.8K |
| YoY Change | -11.82% | 191.85% | -58.34% |
| Depreciation, Depletion And Amortization | $42.23K | $98.87K | |
| YoY Change | -39.29% | -15.37% | |
| Cash From Operating Activities | -$979.6K | -$5.976M | -$620.8K |
| YoY Change | 80.18% | 992.66% | 3.04% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $26.98K | ||
| YoY Change | |||
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $0.00 | ||
| YoY Change | -100.0% | ||
| Cash From Investing Activities | -$26.98K | $0.00 | |
| YoY Change | -91.01% | -100.0% | |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | $32.47K | ||
| YoY Change | 0.99% | ||
| Cash From Financing Activities | -32.55K | $11.43M | 501.3K |
| YoY Change | -106.58% | -220.52% | -25.73% |
| NET CHANGE | |||
| Cash From Operating Activities | -979.6K | -$5.976M | -620.8K |
| Cash From Investing Activities | -26.98K | 0.000 | |
| Cash From Financing Activities | -32.55K | $11.43M | 501.3K |
| Net Change In Cash | -1.039M | $5.456M | -119.5K |
| YoY Change | 198.02% | 1862.81% | -70.67% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$979.6K | -$5.976M | -$620.8K |
| Capital Expenditures | $26.98K | ||
| Free Cash Flow | -$1.007M | ||
| YoY Change |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
9575925 | shares |
| CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
9575925 | shares |
| CY2024Q1 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
602083 | usd |
| CY2023Q1 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
46577 | usd |
| CY2024Q1 | us-gaap |
Gross Profit
GrossProfit
|
760080 | usd |
| CY2023Q1 | us-gaap |
Gross Profit
GrossProfit
|
-39013 | usd |
| CY2024Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
642546 | usd |
| CY2023Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
421887 | usd |
| CY2024Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
5696211 | usd |
| CY2023Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
1291765 | usd |
| CY2024Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
6338757 | usd |
| CY2023Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
1713652 | usd |
| CY2024Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-5578677 | usd |
| CY2023Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1752665 | usd |
| CY2024Q1 | us-gaap |
Other Nonoperating Expense
OtherNonoperatingExpense
|
20931 | usd |
| CY2023Q1 | us-gaap |
Other Nonoperating Expense
OtherNonoperatingExpense
|
0 | usd |
| CY2024Q1 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
23123 | usd |
| CY2023Q1 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
0 | usd |
| CY2024Q1 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
2983100 | usd |
| CY2023Q1 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
0 | usd |
| CY2024Q1 | qti |
Fair Value Adjustment Of Earnout Liability
FairValueAdjustmentOfEarnoutLiability
|
1060000 | usd |
| CY2023Q1 | qti |
Fair Value Adjustment Of Earnout Liability
FairValueAdjustmentOfEarnoutLiability
|
0 | usd |
| CY2024Q1 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-598959 | usd |
| CY2023Q1 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-130282 | usd |
| CY2024Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-4298590 | usd |
| CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-1882947 | usd |
| CY2024Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.33 | |
| CY2024Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.33 | |
| CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.20 | |
| CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.20 | |
| CY2024Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
13225553 | shares |
| CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
13225553 | shares |
| CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
9517098 | shares |
| CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
9517098 | shares |
| CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-5312079 | usd |
| CY2024Q1 | qti |
Stock Issued During Period Value Reverse Recapitalization
StockIssuedDuringPeriodValueReverseRecapitalization
|
-9269165 | usd |
| CY2024Q1 | us-gaap |
Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
|
706000 | usd |
| CY2024Q1 | qti |
Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
|
0 | usd |
| CY2024Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
38984 | usd |
| CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4298590 | usd |
| CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-4914150 | usd |
| CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1507577 | usd |
| CY2023Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
956550 | usd |
| CY2023Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
208628 | usd |
| CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1882947 | usd |
| CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-2225346 | usd |
| CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4298590 | usd |
| CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1882947 | usd |
| CY2024Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
98873 | usd |
| CY2023Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
116826 | usd |
| CY2024Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
38984 | usd |
| CY2023Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
208628 | usd |
| CY2024Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
1290 | usd |
| CY2023Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
0 | usd |
| CY2024Q1 | us-gaap |
Noncash Merger Related Costs
NoncashMergerRelatedCosts
|
3714694 | usd |
| CY2023Q1 | us-gaap |
Noncash Merger Related Costs
NoncashMergerRelatedCosts
|
0 | usd |
| CY2024Q1 | qti |
Loss From Issuance Of Common Stock
LossFromIssuanceOfCommonStock
|
206000 | usd |
| CY2023Q1 | qti |
Loss From Issuance Of Common Stock
LossFromIssuanceOfCommonStock
|
0 | usd |
| CY2024Q1 | us-gaap |
Paid In Kind Interest
PaidInKindInterest
|
298605 | usd |
| CY2023Q1 | us-gaap |
Paid In Kind Interest
PaidInKindInterest
|
10773 | usd |
| CY2024Q1 | qti |
Non Cash Operating Lease Expense
NonCashOperatingLeaseExpense
|
5369 | usd |
| CY2023Q1 | qti |
Non Cash Operating Lease Expense
NonCashOperatingLeaseExpense
|
2062 | usd |
| CY2024Q1 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
23123 | usd |
| CY2023Q1 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
0 | usd |
| CY2024Q1 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
2983100 | usd |
| CY2023Q1 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
0 | usd |
| CY2024Q1 | qti |
Fair Value Adjustment Of Earnout Liability
FairValueAdjustmentOfEarnoutLiability
|
1060000 | usd |
| CY2023Q1 | qti |
Fair Value Adjustment Of Earnout Liability
FairValueAdjustmentOfEarnoutLiability
|
0 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
482357 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
5840 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-586413 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-49051 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
879508 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
34641 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
0 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
-5000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-2118345 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
392219 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-1319572 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
31530 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-3968 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
0 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
|
87312 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
|
118747 | usd |
| CY2024Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-5975515 | usd |
| CY2023Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-992716 | usd |
| CY2024Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | usd |
| CY2023Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
947850 | usd |
| CY2024Q1 | qti |
Proceeds From Issuance Of Common Stock Pursuant To Subscription Agreement
ProceedsFromIssuanceOfCommonStockPursuantToSubscriptionAgreement
|
500000 | usd |
| CY2023Q1 | qti |
Proceeds From Issuance Of Common Stock Pursuant To Subscription Agreement
ProceedsFromIssuanceOfCommonStockPursuantToSubscriptionAgreement
|
0 | usd |
| CY2024Q1 | us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
10525000 | usd |
| CY2023Q1 | us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
0 | usd |
| CY2024Q1 | us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
32470 | usd |
| CY2023Q1 | us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
32153 | usd |
| CY2024Q1 | us-gaap |
Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
|
800000 | usd |
| CY2023Q1 | us-gaap |
Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
|
0 | usd |
| CY2024Q1 | qti |
Proceeds From Reverse Recapitalization Transaction
ProceedsFromReverseRecapitalizationTransaction
|
1238530 | usd |
| CY2023Q1 | qti |
Proceeds From Reverse Recapitalization Transaction
ProceedsFromReverseRecapitalizationTransaction
|
0 | usd |
| CY2024Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
11431060 | usd |
| CY2023Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
915697 | usd |
| CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
5455545 | usd |
| CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-77019 | usd |
| CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
184686 | usd |
| CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
475076 | usd |
| CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
5640231 | usd |
| CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
398057 | usd |
| CY2024Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
160545 | usd |
| CY2023Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | usd |
| CY2024Q1 | qti |
Fair Value Of Embedded Derivatives Upon Issuance Of Convertible Debt
FairValueOfEmbeddedDerivativesUponIssuanceOfConvertibleDebt
|
5120900 | usd |
| CY2023Q1 | qti |
Fair Value Of Embedded Derivatives Upon Issuance Of Convertible Debt
FairValueOfEmbeddedDerivativesUponIssuanceOfConvertibleDebt
|
0 | usd |
| CY2024Q1 | qti |
Fair Value Of Common Stock Issued With Convertible Debt
FairValueOfCommonStockIssuedWithConvertibleDebt
|
2312617 | usd |
| CY2023Q1 | qti |
Fair Value Of Common Stock Issued With Convertible Debt
FairValueOfCommonStockIssuedWithConvertibleDebt
|
0 | usd |
| CY2024Q1 | qti |
Transfer Of Equipment To Inventory
TransferOfEquipmentToInventory
|
284444 | usd |
| CY2023Q1 | qti |
Transfer Of Equipment To Inventory
TransferOfEquipmentToInventory
|
0 | usd |
| CY2024Q1 | qti |
Extinguishment Of Accrued Expenses In Exchange For Common Stock
ExtinguishmentOfAccruedExpensesInExchangeForCommonStock
|
3760000 | usd |
| CY2023Q1 | qti |
Extinguishment Of Accrued Expenses In Exchange For Common Stock
ExtinguishmentOfAccruedExpensesInExchangeForCommonStock
|
0 | usd |
| CY2024Q1 | qti |
Debt Discount Incurred During Noncash Or Partial Noncash Transaction
DebtDiscountIncurredDuringNoncashOrPartialNoncashTransaction
|
40740 | usd |
| CY2023Q1 | qti |
Debt Discount Incurred During Noncash Or Partial Noncash Transaction
DebtDiscountIncurredDuringNoncashOrPartialNoncashTransaction
|
0 | usd |
| CY2024Q1 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
3433388 | usd |
| CY2023Q1 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
0 | usd |
| CY2024Q1 | qti |
Recapitalization Exchange Ratio
RecapitalizationExchangeRatio
|
0.3427 | |
| CY2024Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-22068735 | usd |
| CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4298590 | usd |
| CY2024Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-5975515 | usd |
| CY2024Q1 | qti |
Triggered Event Daily Volume Weighted Average Price Per Share
TriggeredEventDailyVolumeWeightedAveragePricePerShare
|
2.00 | |
| CY2024Q1 | qti |
Number Of Consecutive Trading Days
NumberOfConsecutiveTradingDays
|
5 | d |
| CY2024Q1 | us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<div style="margin-top:18pt;padding-left:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassification</span></div><div style="margin-top:6pt;padding-left:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications have been made to the prior year condensed consolidated statement of operations and comprehensive loss to conform to the current year presentation. The reclassification had no impact on the previously reported condensed consolidated balance sheet, statement of stockholders’ deficit or cash flows.</span></div> | |
| CY2024Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="margin-top:18pt;padding-left:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;padding-left:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, and expenses and the related disclosure of contingent assets and liabilities. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates. In addition, any change in these estimates or their related assumptions could have an adverse effect on the Company’s operating results.</span></div> | |
| CY2024Q1 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="margin-top:18pt;padding-left:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business Risk and Concentration of Credit Risk and Supply Risk</span></div><div style="margin-top:6pt;padding-left:24.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and accounts receivable. The majority of the Company’s cash is invested in U.S. dollar deposits with a reputable bank in the United States. Management believes that minimal credit risk exists with respect to the financial institution that holds the Company’s cash. At times, such cash may be in excess of insured limits established by the Federal Deposit Insurance Corporation.</span></div><div style="margin-top:6pt;padding-left:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performs ongoing credit evaluations of its customers and generally does not require collateral for accounts receivable. Payment terms range from cash in advance to 30 days from delivery of products or services but may fluctuate depending on the terms of each specific contract. During the three months ended March 31, 2024, two customers represented 99% of revenue. During the three months ended March 31, 2023, two customers represented 100% of revenue. As of March 31, 2024, one customer represented 93% of accounts receivable. As of December 31, 2023, one customer represented 100% of accounts receivable.</span></div><div style="margin-top:6pt;padding-left:24.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain components and services used to manufacture and develop the Company’s products are presently available from only one or a limited number of suppliers or vendors. The loss of any of these suppliers or vendors would potentially require a significant level of hardware and/or software development efforts to incorporate the products or services into the Company’s product.</span></div> | |
| CY2024Q1 | qti |
Payment Term Range Cash In Advance Duration
PaymentTermRangeCashInAdvanceDuration
|
P30D | |
| CY2024Q1 | us-gaap |
Restricted Cash Equivalents
RestrictedCashEquivalents
|
20000 | usd |
| CY2023Q4 | us-gaap |
Restricted Cash Equivalents
RestrictedCashEquivalents
|
20000 | usd |
| CY2024Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
1290 | usd |
| CY2023Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
0 | usd |
| CY2023Q4 | us-gaap |
Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
|
0 | usd |
| CY2024Q1 | us-gaap |
Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
|
0 | usd |
| CY2024Q1 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
0 | usd |
| CY2023Q1 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
0 | usd |
| CY2024Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
1362163 | usd |
| CY2023Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
7564 | usd |
| CY2024Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
1362163 | usd |
| CY2023Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
7564 | usd |
| CY2024Q1 | us-gaap |
Contract With Customer Asset Net
ContractWithCustomerAssetNet
|
0 | usd |
| CY2023Q4 | us-gaap |
Contract With Customer Asset Net
ContractWithCustomerAssetNet
|
0 | usd |
| CY2024Q1 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
343651 | usd |
| CY2023Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
347619 | usd |
| CY2024Q1 | qti |
Product Warranty Duration
ProductWarrantyDuration
|
P6M | |
| CY2024Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
642546 | usd |
| CY2023Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
421887 | usd |
| CY2023Q1 | us-gaap |
Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
|
0 | usd |
| CY2024Q1 | us-gaap |
Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
|
0 | usd |
| CY2024Q1 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
2509875 | usd |
| CY2023Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
2529364 | usd |
| CY2024Q1 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
1405128 | usd |
| CY2023Q4 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
1627802 | usd |
| CY2024Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
44026202 | shares |
| CY2023Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
1993891 | shares |
| CY2024Q1 | qti |
Recapitalization Exchange Ratio
RecapitalizationExchangeRatio
|
0.3427 | |
| CY2024Q1 | qti |
Cash Acquired Through Reverse Recapitalization Trust
CashAcquiredThroughReverseRecapitalizationTrust
|
13952525 | usd |
| CY2024Q1 | qti |
Cash Acquired Through Reverse Recapitalization Operating Cash
CashAcquiredThroughReverseRecapitalizationOperatingCash
|
4829 | usd |
| CY2024Q1 | qti |
Payments Made Pursuant To Non Redemption Agreements
PaymentsMadePursuantToNonRedemptionAgreements
|
10791550 | usd |
| CY2024Q1 | qti |
Payments Of Reverse Recapitalization Transaction Costs
PaymentsOfReverseRecapitalizationTransactionCosts
|
1073667 | usd |
| CY2024Q1 | us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
853607 | usd |
| CY2024Q1 | qti |
Proceeds From Reverse Recapitalization Transaction
ProceedsFromReverseRecapitalizationTransaction
|
1238530 | usd |
| CY2024Q1 | us-gaap |
Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
|
10507695 | usd |
| CY2024Q1 | qti |
Reverse Recapitalization Net
ReverseRecapitalizationNet
|
-9269165 | usd |
| CY2024Q1 | qti |
Number Of Additional Subscription Agreements
NumberOfAdditionalSubscriptionAgreements
|
2 | agreement |
| CY2023Q4 | qti |
Warrant Liability
WarrantLiability
|
0 | usd |
| CY2024Q1 | qti |
Warrant Liability Assumed
WarrantLiabilityAssumed
|
8894 | usd |
| CY2024Q1 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
23123 | usd |
| CY2024Q1 | qti |
Warrant Liability
WarrantLiability
|
32017 | usd |
| CY2024Q1 | qti |
Monthly Payment Discount Triggered Principal Amount
MonthlyPaymentDiscountTriggeredPrincipalAmount
|
1500000 | usd |
| CY2024Q1 | qti |
Monthly Payment Discount Triggered Percentage
MonthlyPaymentDiscountTriggeredPercentage
|
0.50 | |
| CY2024Q1 | qti |
Monthly Payment Discount Triggered Percentage
MonthlyPaymentDiscountTriggeredPercentage
|
0.50 | |
| CY2024Q1 | qti |
Variable Price Conversion Right Conversion Price Percentage
VariablePriceConversionRightConversionPricePercentage
|
0.95 | |
| CY2024Q1 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
201225 | usd |
| CY2023Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
261031 | usd |
| CY2024Q1 | us-gaap |
Inventory Net
InventoryNet
|
4116228 | usd |
| CY2023Q4 | us-gaap |
Inventory Net
InventoryNet
|
4418197 | usd |
| CY2024Q1 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
4730675 | usd |
| CY2023Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
5213649 | usd |
| CY2024Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
4576602 | usd |
| CY2023Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
4722729 | usd |
| CY2024Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
154073 | usd |
| CY2023Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
490920 | usd |
| CY2024Q1 | us-gaap |
Depreciation
Depreciation
|
52403 | usd |
| CY2023Q1 | us-gaap |
Depreciation
Depreciation
|
70356 | usd |
| CY2024Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
46470 | usd |
| CY2023Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
46470 | usd |
| CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
|
43669 | usd |
| CY2024Q1 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
910208 | usd |
| CY2023Q4 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
9808 | usd |
| CY2024Q1 | qti |
Prepaid Licenses And Subscriptions Current
PrepaidLicensesAndSubscriptionsCurrent
|
99493 | usd |
| CY2023Q4 | qti |
Prepaid Licenses And Subscriptions Current
PrepaidLicensesAndSubscriptionsCurrent
|
8536 | usd |
| CY2024Q1 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
185588 | usd |
| CY2023Q4 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
196635 | usd |
| CY2024Q1 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
1195289 | usd |
| CY2023Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
214979 | usd |
| CY2024Q1 | us-gaap |
Litigation Reserve Current
LitigationReserveCurrent
|
2065739 | usd |
| CY2023Q4 | us-gaap |
Litigation Reserve Current
LitigationReserveCurrent
|
24729 | usd |
| CY2024Q1 | us-gaap |
Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
|
202341 | usd |
| CY2023Q4 | us-gaap |
Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
|
0 | usd |
| CY2024Q1 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
100000 | usd |
| CY2023Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
0 | usd |
| CY2024Q1 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
445182 | usd |
| CY2023Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
344922 | usd |
| CY2024Q1 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
2813262 | usd |
| CY2023Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
369651 | usd |
| CY2024Q1 | us-gaap |
Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
|
97896 | usd |
| CY2024Q1 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
|
11586784 | usd |
| CY2024Q1 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
|
9198 | usd |
| CY2024Q1 | us-gaap |
Long Term Debt
LongTermDebt
|
11693878 | usd |
| CY2024Q1 | us-gaap |
Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
|
8232488 | usd |
| CY2024Q1 | qti |
Long Term Debt Current Maturities Excluding Notes Payable
LongTermDebtCurrentMaturitiesExcludingNotesPayable
|
130698 | usd |
| CY2024Q1 | qti |
Long Term Debt Excluding Current Maturities And Notes Payable
LongTermDebtExcludingCurrentMaturitiesAndNotesPayable
|
3330692 | usd |
| CY2024Q1 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
1186815 | usd |
| CY2023Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
1267121 | usd |
| CY2024Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
372010 | usd |
| CY2023Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
361305 | usd |
| CY2024Q1 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
966253 | usd |
| CY2023Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
1062633 | usd |
| CY2024Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
1338263 | usd |
| CY2023Q4 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
1423938 | usd |
| CY2024Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
113586 | usd |
| CY2023Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
110278 | usd |
| CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
348710 | usd |
| CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
476164 | usd |
| CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
490449 | usd |
| CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
206864 | usd |
| CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
1522187 | usd |
| CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
183924 | usd |
| CY2024Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
1338263 | usd |
| CY2024Q1 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
113535 | usd |
| CY2023Q1 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
113283 | usd |
| CY2024Q1 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P3Y2M12D | |
| CY2024Q1 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.08 | |
| CY2024Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
500000000 | shares |
| CY2024Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
21437216 | shares |
| CY2024Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2024Q1 | qti |
Number Of Entitled Vote
NumberOfEntitledVote
|
1 | vote |
| CY2024Q1 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
46384295 | shares |
| CY2024Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
| CY2024Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
| CY2023Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2024Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2023Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2024Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2024Q1 | qti |
Share Based Compensation Arrangement By Share Based Payment Award Options Issued Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIssuedNumber
|
0 | shares |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
0 | shares |
| CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
0 | shares |
| CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
0 | shares |
| CY2024Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
38984 | usd |
| CY2023Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
208628 | usd |
| CY2024Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
0 | usd |
| CY2022Q3 | us-gaap |
Grants Receivable
GrantsReceivable
|
1078347 | usd |
| CY2022Q3 | qti |
Grants Receivable Term
GrantsReceivableTerm
|
P5Y | |
| CY2022Q3 | qti |
Grant Receivable Written Notice Termination Period
GrantReceivableWrittenNoticeTerminationPeriod
|
P30D | |
| CY2024Q1 | qti |
Total Costs Incurred Grants Costs
TotalCostsIncurredGrantsCosts
|
356436 | usd |
| CY2024Q1 | qti |
Costs Incurred Grants Costs
CostsIncurredGrantsCosts
|
7382 | usd |
| CY2023Q1 | qti |
Costs Incurred Grants Costs
CostsIncurredGrantsCosts
|
12235 | usd |
| CY2024Q1 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | |
| CY2023Q1 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | |
| CY2024Q1 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | |
| CY2023Q1 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0 | |
| CY2023Q2 | qti |
Number Of Restatement
NumberOfRestatement
|
6 | restatement |
